Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cerilliant
Daiichi Sankyo
Federal Trade Commission
Healthtrust
US Department of Justice
Chubb
McKinsey
UBS
Fuji

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088207

« Back to Dashboard
NDA 088207 describes GERIMAL, which is a drug marketed by Watson Labs and is included in three NDAs. Additional details are available on the GERIMAL profile page.

The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.

Summary for NDA: 088207

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength1MG
Approval Date:Mar 22, 1984TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Moodys
Merck
Novartis
Fuji
Baxter
Harvard Business School
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot